Literature DB >> 18031563

Prevalence of cervicogenic headache: Vågå study of headache epidemiology.

O Sjaastad1, L S Bakketeig.   

Abstract

OBJECTIVES: To describe the prevalence and various clinical characteristics of cervicogenic headache (CEH) in the population at large.
METHODS: CEH was searched for in Vågå, Norway, where 1838 18 to 65-year-old citizens, i.e. 88.6% of this age group, underwent an interview/clinical examination. The Cervicogenic Headache International Study Group criteria include: (I) unilaterality of head pain, (II) reduction, range of movement, neck, (III/IV) ipsilateral shoulder/arm discomfort, (V/VI) mechanical provocation of similar pain, objectively or subjectively.
RESULTS: A prevalence of 4.1% was found. In 41 cases with the highest number of CEH criteria ('core' cases), there was a male preponderance (F/M: 0.71). While cervicogenic traits (mechanical precipitation etc.) were frequently present in CEH, 'migraine traits', like nausea, vomiting, and throbbing seemed to be rarely present. In 97% of the cases, pain exacerbations began in the neck/occipital region.
CONCLUSIONS: CEH may be one of the three large, recurrent headaches. In this series, there was no female preponderance. Nuchal onset of pain is a characteristic trait.

Entities:  

Mesh:

Year:  2007        PMID: 18031563     DOI: 10.1111/j.1600-0404.2007.00962.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  37 in total

1.  Cervicogenic headache: a real headache.

Authors:  Fabio Antonaci; Ottar Sjaastad
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

Review 2.  Occipital Neuralgia and Cervicogenic Headache: Diagnosis and Management.

Authors:  Rebecca Barmherzig; William Kingston
Journal:  Curr Neurol Neurosci Rep       Date:  2019-03-19       Impact factor: 5.081

3.  Headache symptom modification: the relevance of appropriate manual therapy assessment and management of a patient with features of migraine and cervicogenic headache - a case report.

Authors:  Kiran Satpute; Nilima Bedekar; Toby Hall
Journal:  J Man Manip Ther       Date:  2019-09-20

4.  Spinal rehabilitative exercise or manual treatment for the prevention of cervicogenic headache in adults.

Authors:  Mitchell Haas; Gert Brønfort; Roni L Evans; Brent Leininger; John Schmitt; Morris Levin; Kristine Westrom; Charles H Goldsmith
Journal:  Cochrane Database Syst Rev       Date:  2016-05-27

5.  Cervico-cephalalgiaphobia: a subtype of phobia in patients with cervicogenic headache and neck pain? A pilot study.

Authors:  Rob A B Oostendorp; Hans Elvers; Emilia Mikolajewska; Nathalie Roussel; Emiel van Trijffel; Han Samwel; Jo Nijs; William Duquet
Journal:  J Man Manip Ther       Date:  2016-09

6.  Pulsed radiofrequency of the C2 dorsal root ganglion and epidural steroid injections for cervicogenic headache.

Authors:  Shao-Jun Li; Dan Feng
Journal:  Neurol Sci       Date:  2019-03-07       Impact factor: 3.307

Review 7.  Cervicogenic headache: a review comparison with migraine, tension-type headache, and whiplash.

Authors:  Maurice B Vincent
Journal:  Curr Pain Headache Rep       Date:  2010-06

8.  Dose response and efficacy of spinal manipulation for chronic cervicogenic headache: a pilot randomized controlled trial.

Authors:  Mitchell Haas; Adele Spegman; David Peterson; Mikel Aickin; Darcy Vavrek
Journal:  Spine J       Date:  2010-02       Impact factor: 4.166

9.  A pilot study to investigate the short-term effects of specific soft tissue massage on upper cervical movement impairment in patients with cervicogenic headache.

Authors:  Diana Hopper; Yogita Bajaj; Chor Kei Choi; Osama Jan; Toby Hall; Kim Robinson; Kathy Briffa
Journal:  J Man Manip Ther       Date:  2013-02

10.  Preliminary results, methodological considerations and recruitment difficulties of a randomised clinical trial comparing two treatment regimens for patients with headache and neck pain.

Authors:  Willem De Hertogh; Peter Vaes; Dirk Devroey; Paul Louis; Hans Carpay; Steven Truijen; William Duquet; Rob Oostendorp
Journal:  BMC Musculoskelet Disord       Date:  2009-09-23       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.